Ulmus Americana, Fagus Grandifolia, Populus Deltoides, Quercus Rubra, Betula Nigra, Carya Ovata And Fraxinus Americana
Generic Name: ulmus americana, fagus grandifolia, populus deltoides, quercus rubra, betula nigra, carya ovata and fraxinus americana
Brand Names:
Eastern 7 Tree Pollen Mix
Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: BETULA NIGRA POLLEN (5714.2857 [PNU]/mL); CARYA OVATA POLLEN (5714.2857 [PNU]/mL); FAGUS GRANDIFOLIA POLLEN (5714.2857 [PNU]/mL); FRAXINUS AMERICANA POLLEN (5714.2857 [PNU]/mL); POPULUS DELTOIDES POLLEN (5714.2857 [PNU]/mL); QUERCUS RUBRA POLLEN (5714.2857 [PNU]/mL); ULMUS AMERICANA POLLEN (5714.2857 [PNU]/mL). Category: BLA.
Overview
Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: BETULA NIGRA POLLEN (5714.2857 [PNU]/mL); CARYA OVATA POLLEN (5714.2857 [PNU]/mL); FAGUS GRANDIFOLIA POLLEN (5714.2857 [PNU]/mL); FRAXINUS AMERICANA POLLEN (5714.2857 [PNU]/mL); POPULUS DELTOIDES POLLEN (5714.2857 [PNU]/mL); QUERCUS RUBRA POLLEN (5714.2857 [PNU]/mL); ULMUS AMERICANA POLLEN (5714.2857 [PNU]/mL). Category: BLA.
Dosage
Available as solution for intradermal, percutaneous, subcutaneous use.
Related Medications
Lumateperone
lumateperone
Atypical Antipsychotic [EPC]
11 DESCRIPTION Lumateperone is an atypical antipsychotic present as lumateperone tosylate salt with the chemical name 4-((6b R ,10a S )-3-methyl-2,3,6b,9,10,10 a -hexahydro-1 H ,7 H -pyrido[3',4':4,5]pyrrolo[1,2,3- de ]quinoxalin-8-yl)-1-(4-fluoro-phenyl)-butan-1-one 4-methylbenzenesulfonate. Its molecular formula is C 31 H 36 FN 3 O 4 S, and its molecular weight is 565.71 g/mol with the following structure: CAPLYTA (lumateperone) capsules are for oral administration.
Dried Aluminium Hydroxide
dried aluminium hydroxide
Dosage form: POWDER. Active ingredients: ALUMINUM HYDROXIDE (1 kg/kg). Category: BULK INGREDIENT.
Ustekinumab-auub
ustekinumab-auub
Interleukin-12 Antagonist [EPC]
11 DESCRIPTION Ustekinumab-auub, a human IgG1κ monoclonal antibody, is a human interleukin -12 and -23 antagonist. Using DNA recombinant technology, ustekinumab-auub is produced in a mammalian cell line (Chinese Hamster Ovary). The manufacturing process contains steps for the clearance of viruses. Ustekinumab-auub is comprised of 1326 amino acids and has an estimated molecular mass that ranges from 148 to 150 kDa.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.